Ozempic’s unconventional origins
The Story of Money10 Tammi 2024

Ozempic’s unconventional origins

The runaway success of diabetes and weight-loss drugs Ozempic and Wegovy have turned their maker, Novo Nordisk, into a juggernaut. Last year the Danish drugmaker claimed the title of Europe’s most valuable company. But the development of these drugs was a long, uphill battle.The FT’s global pharmaceutical editor Hannah Kuchler explains how the company’s unique ownership structure played a critical role in the company’s achievements and looks at the challenges ahead.


Clips from CNBC, CBS, Reuters

- - - - - - - - - - - - - - - - - - - - - - - - - -

Subscribe and listen to Untold: The Retreat on Apple Podcasts, Spotify or wherever you get your podcasts.

- - - - - - - - - - - - - - - - - - - - - - - - - -

For further reading:

FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk

How anti-obesity drugs built the world’s largest charitable foundation

Obesity drugs: broadly good for investors, with some strictures

Covid-19 vaccine winners suffer reversal of fortune

- - - - - - - - - - - - - - - - - - - - - - - - - -

On X, follow Hannah Kuchler (@hannahkuchler) and Michela Tindera (@mtindera07), or follow Michela on LinkedIn for updates about the show and more.


Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Jaksot(319)

KKR, Bain and private equity’s push into Japan

KKR, Bain and private equity’s push into Japan

When international private equity groups first entered Japan at the turn of the 21st century, newspapers criticised them as vulture funds and politicians steered clear of public contact. Today, it’s a...

26 Marras 202521min

Coming soon from Tech Tonic: Defying death

Coming soon from Tech Tonic: Defying death

Investors are spending billions of dollars on novel ways to extend human life through inventive treatments, therapies, and even manipulating our genes. And increasingly, it seems as though anti-ageing...

24 Marras 20251min

What’s the deal with OpenAI's deals?

What’s the deal with OpenAI's deals?

OpenAI is entering a new era. It's restructured to add a for-profit arm to its business and has signed more than a trillion dollars’ worth of deals to secure chips and build out data centres. But thos...

19 Marras 202526min

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs

Pharma juggernauts Pfizer and Novo Nordisk are struggling in the obesity drug race.The two companies are searching for their next moneymaker, and that search recently spun out into a ferocious, multib...

12 Marras 202526min

The $17bn nuclear start-up without any revenue

The $17bn nuclear start-up without any revenue

Publicly-listed Oklo sits at the intersection of two hot areas for Wall Street: artificial intelligence and energy companies. This year alone, Oklo’s share price has jumped more than 400 per cent. But...

5 Marras 202523min

$12bn of debt: How First Brands Group collapsed

$12bn of debt: How First Brands Group collapsed

Some of the world’s biggest financial institutions are reeling after the collapse of a little-known car parts supplier: First Brands Group. The company filed for bankruptcy last month, and since then,...

29 Loka 202526min

Can the world’s largest listed hedge fund rebound?

Can the world’s largest listed hedge fund rebound?

The world’s largest listed hedge fund manager, Man Group, is at a crossroads. After years of high flying thanks to its innovative quant trading strategies, the company’s hedge fund unit has been falte...

22 Loka 202519min

Introducing Untold: Toxic Legacy

Introducing Untold: Toxic Legacy

Introducing Toxic Legacy, a new season of Untold from the Financial Times. Host Laura Hughes uncovers a lead poisoning epidemic across the UK. You might be living with lead and not know it: the toxin ...

16 Loka 20252min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
hyva-paha-johtaminen
ostan-asuntoja-podcast
rss-rahamania
rss-sami-miettinen-neuvottelija
rss-lahtijat
rss-rentotapaus
kultaiset-hoitajat
rss-startup-ministerio
rss-seuraava-potilas
herrasmieshakkerit
rss-strategian-seurassa
asuntoasiaa-paivakirjat
rss-h-asselmoilanen
rss-tyoelamasta-podcast
rss-vaikuttavan-opettajan-vierella
rss-set-for-life-sijoita-ja-vaurastu